Literature DB >> 33389192

Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatosplenectomy (CDPS) for left-sided pancreatic ductal adenocarcinoma.

Menghua Dai1, Hanyu Zhang2, Yatong Li2, Cheng Xing2, Cheng Ding2, Quan Liao2, Taiping Zhang2, Junchao Guo2, Qiang Xu2, Xianlin Han2, Wenjing Liu2, Qiaofei Liu2.   

Abstract

PURPOSE: The insufficient clearance of regional lymph nodes and unsatisfactory R0 resection rate may result in the metastasis of left-sided pancreatic ductal adenocarcinoma (PDAC) after conventional distal pancreatosplenectomy (CDPS). Radical antegrade modular pancreatosplenectomy (RAMPS) was designed to achieve R0 resection more successfully with better lymph-node clearance; however, there is still insufficient evidence of its short- and long-term results to confirm its superiority. We conducted this study to compare the efficiency of these two procedures.
METHODS: The subjects of this retrospective analysis were 103 patients with left-sided PDAC who underwent either RAMPS (n = 46) or CDPS (n = 57). We assessed perioperative data and surgical information and used univariate and multivariate analyses to identify prognostic factors for survival.
RESULTS: There were no significant differences in baseline data between the groups. RAMPS was associated with a significantly shorter hospital stay (12.11 days vs. 22.98 days; P < 0.001), and significantly less blood loss (451.09 ml vs. 764.04 ml, P = 0.002), as well as a significantly lower rate of blood transfusion (15.22% vs. 33.33%, P = 0.035). RAMPS and CDPS had comparable perioperative complication rates. Moreover, RAMPS achieved more effective lymph-node retrieval (17.87 vs. 10.23; P < 0.001). The RAMPS group had a higher overall survival (OS) rate (28.73 months vs. 18.30 months; P = 0.003) and a higher disease-free survival (DFS) rate (21.97 months vs. 9.40 months; P < 0.001).
CONCLUSION: RAMPS achieved better survival and surgical outcomes than CDPS for patients with left-sided PDAC.

Entities:  

Keywords:  Pancreatic ductal adenocarcinoma; Pancreatosplenectomy; R0 resection; RAMPS; Survival

Year:  2021        PMID: 33389192     DOI: 10.1007/s00595-020-02203-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  3 in total

1.  Complications in Distal Pancreatectomy versus Radical Antegrade Modular Pancreatosplenectomy: A Disease Risk Score Analysis Utilizing National Surgical Quality Improvement Project Data.

Authors:  Thomas L Sutton; Kristin C Potter; Skye C Mayo; Rodney Pommier; Erin W Gilbert; Brett C Sheppard
Journal:  World J Surg       Date:  2022-04-11       Impact factor: 3.282

2.  Clinical outcome comparison of laparoscopic radical antegrade modular pancreatosplenectomy vs. laparoscopic distal pancreatosplenectomy for left-sided pancreatic ductal adenocarcinoma surgical resection.

Authors:  Nan Niu; Yuhui He; Yiping Mou; Sijia Meng; Peng Xu; Yucheng Zhou; Weiwei Jin; Chao Lu; Yunyun Xu; Qicong Zhu; Tao Xia
Journal:  Front Surg       Date:  2022-09-01

3.  The effect of minimally invasive or open radical antegrade modular pancreatosplenectomy on pancreatic cancer: A multicenter randomized clinical trial protocol.

Authors:  Menghua Dai; Hanyu Zhang; Yinmo Yang; Dianrong Xiu; Bing Peng; Bei Sun; Feng Cao; Zheng Wu; Lei Wang; Chunhui Yuan; Hua Chen; Zheng Wang; Xiaodong Tian; Hangyan Wang; Wenjing Liu; Jianwei Xu; Qiaofei Liu; Yupei Zhao
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.